NewLink Genetics (NLNK) Announces EU Regulatory Committee Recommendation for Conditional Marketing Authorization for Ebola Vaccine V920

October 21, 2019 4:55 PM

NewLink Genetics Corporation (NASDAQ: NLNK) announced today that Friday, October 18th, the European Medicines Agency (EMA) Committee for Medicinal Products ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found